Venous thromboembolism in end-stage renal disease

American Journal of Kidney Diseases

Volumn 36, Issue 2, 2000, Pages 405-411

  Casserly, Liam F ^a   Reddy, Suman M ^a   Dember, Laura M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deep venous thrombosis (DVT); End stage renal disease (ESRD); Pulmonary embolism (PE); Thromboembolic disease

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LUNG EMBOLISM; MALE; OLIGOPHRENIA; RISK FACTOR; THROMBOEMBOLISM;

EID: 0034255650     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.8983     Document Type: Article

References (39)

1. Ifudu O, Delaney VB, Barth RH, Friedman EA: Deep vein thrombosis in end-stage renal disease. ASAIO J 40:103-105,1994
2. Holley JL: Acute complications during hemodialysis, in Rose BR (ed): Up to Date. Wellesley, MA, Up to Date Inc, 1999
3. Hyers TM: Venous thromboembolism. Am J Respir Crit Care Med 159:1-14, 1999
4. Rotter W, Roettger P: Comparative pathologic-anatomic study of cases of global renal insufficiency with and without preceding hemodialysis. Clin Nephrol 1:257-265, 1973
5. Roettger P, Jorns U: Statistiche Untersuchungen zur Lungenembolie-Haufigkeit im Sektionsgut. Zenbl allg Path path Anat 114:106, 1971 (abstr)
6. Mossey RT, Kasabian AA, Wilkes BM, Mailloux LU, Susin M, Bluestone PA: Pulmonary embolism. Low incidence in chronic renal failure. Arch Intern Med 142:1646-1648, 1982
7. Guntupalli K, Soffer O, Baciewicz P: Pulmonary embolism in end-stage renal disease. Intensive Care Med 16:405-407, 1990
8. Wiesholzer M, Kitzwogerer M, Ferdinand H, Barbieri G, Hauser A-C, Pribasnig A, Bankl H, Balcke P: Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin. Am J Kidney Dis 33:702-708, 1999
9. Stein PD, Henry JW: Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108:978-981, 1995
10. Daten JE, Alpert JS: Natural history of pulmonary embolism. Prog Cardiovasc Dis 17:259-270, 1975
11. Hanzlik R, Baker P: Case of the month: Institutional autopsy rates. Arch Intern Med 158:1171-1172,1998
12. Francioli P, Masur H: Complications of Staphylococcus aureus bacteremia. Occurrence in patients undergoing long-term hemodialysis. Arch Intern Med 142:1655-1658, 1982
13. Goodwin NJ, Castronuovo JJ, Friedman EA: Recurrent septic pulmonary embolization complicating maintenance hemodialysis. Ann Intern Med 71:29-38,1969
14. Kjellstrand CM, Marion GE, Maurer SM, Casali R, Buselmeier TJ: Complications of percutaneous femoral catherization for hemodialysis. Clin Nephrol 4:37-40, 1975
15. Nsouli KA, Lazarus JM, Schoenbaum SC, Gottlieb MN, Lowrie EG, Shocair M: Bacteremic infection in hemodialysis. Arch Intern Med 139:1255-1258M979
16. Schmidt P, Zargornick J, Kopsa H, Kotzaurek R: Septicaemia and pulmonary embolism complicating maintenance hemodialysis. Lancet 1:1129, 1972 (letter)
17. Smits HFM, Van Rijk PP, Van Isselt JW, Mali WPTM, Koomans HA, Blankestijn PJ: Pulmonary embolism after thrombolysis of hemodialysis grafts. J Am Soc Nephrol 8:1458-1461,1997
18. Swan TL, Smyth SH, Berman SS, Pond GD: Pulmonary embolism following hemodialysis access thrombolysis/thrombectomy. J Vase Intervent Radiol 6:683-686, 1995
19. Beathard GA: Thrombolysis versus surgery for the treatment of thrombosed dialysis access grafts. J Am Soc Nephrol 6:1619-1624,1995
20. Wagner R, Mattes J, Traindl O: Deep venous throm-bosis in hemodialysis patients - A pointer to the presence of malignancy. Nephrol Dial Transplant 11:879-880,1996
21. Maruyama H, Geyjo F, Hanano M, Arakawa M: Acquired type 2 protein C deficiency in a long-term hemodialysis patient. Nephron 66:348-350,1994
22. Bostom AG, Lathrop L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:ID20, 1997
23. Den Heijer M, Blom HJ, Gerritis WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ: Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 345:882-885,1995
24. Den Heijer M, Koster T, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR: Hyperhomocysteinemia as a risk factor for deep-vein thombosis. N Engl J Med 334:759-762,1996
25. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G: Plasma parameters of the prothrombotic state in chronic uremia. Nephron 63:273-278,1993
26. Irish A: Cardiovascular disease, fibrinogen and the acute phase response: Associations with lipids and blood pressure in patients with chronic renal disease. Atherosclerosis 137:133-139,1998
27. Camici M, Evangelisti L, Balestri P, Cioni L, Rindi P, Sagripanti A, Meriggioli M, Giordani R: Coagulation activation in extracorporeal hemodialysis. Int J Artif Organs 20:163-165,1997
28. Alwakeel J, Gader AM, Hurieb S, al-Momen AK, Mitwalli A, Abu Aisha H: Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and hemodialysis. Int J Urol Nephrol 28:255-261,1996
29. Mehta RL, Scott G, Sloand JA, Francis CW: Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis. Am J Med 88:252-257,1990
30. Eberst ME, Berkowitz LR: Hemostasis in renal disease: Pathophysiology and management. Am J Med 96:168-179,1994
31. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley R, Korbet S, Krantz SB, Lundin AP, Nissenson AR, Ogden DA, Paganini EP, Rader B, Rutsky EA, Stivelman J, Stone WJ, Teschan P, Van Stone JC, Van Wyck DB, Zuckerman K, Adamson JW: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase 3 multicenter clinical trial. Ann Intern Med 111:992-1000,1989
32. Churchill DN, Muirhead N, Goldstein M, Posen G, Fay W, Beecroft ML, Gorman J, Taylor DW: Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin. J Am Soc Nephrol 4:1809-1813,1994
33. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736,1996
34. Bergstrom J, Lindholm B: Malnutrition, cardiac disease and mortality: An integrated point of view. Am J Kidney Dis 32:834-841,1998
35. Churchill DN, Taylor W, Cook RJ, La Plante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, McKenzie JK, Muirhead N, Parfrey PS, Posen GA, Slaughter D, Ulan RA, Werb R: Canadian hemodialysis morbidity study. Am J Kidney Dis 19:214-234,1992
36. Lowe GDO, Drummond MM, Lorimer AR, Hutton I, Forbes CD, Prentice CRM, Barbenel JC: Relation between extent of coronary artery disease and blood viscosity. Br Med J 280:673-674,1980
37. Junker R, Henrich J, Schulte H, Schonfeld R, Kohler E, Assmann G: Relationship between plasma viscosity and the severity of coronary heart disease. Arterioscler Thromb Vase Biol 18:870-875,1998
38. Kario K, Matsuo T, Kobayashi H: Heparin cofactor 2 deficiency in the elderly: Comparison with antithrombin 3. Thromb Res 66:489-498,1992
39. US Renal Data System: Incidence and prevalence of ESRD. Am J Kidney Dis 32:S38-S49,1998 (suppl 1)